We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Liquid Biopsies – News and Features

News

Affymetrix and ScreenCell Announce Worldwide Distribution Agreement

Affymetrix releases first circulating tumour cell platform technology for 4-color RNA-ISH.
News

Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for CTC Technology

Combination of ScreenCell’s isolation devices and Affymetrix’ QuantiGene® ViewRNA ISH technology enables easy, accessible, sensitive, multiplex, low-cost system to enumerate and characterize CTCs and other rare cells.
News

Ariosa Diagnostics Announces Completion of Laboratory-Developed Test Study for Prenatal Test

Company to present additional Harmony(TM) Prenatal Test data at the 2012 American College of Medical Genetics Annual Clinical Genetics Meeting.
News

Comparison of Microfluidic Digital PCR and Conventional Quantitative PCR for Measuring Copy Number Variation

This study uses an in vitro BC gene amplification model to identify when a CNV is too small to be measured by qPCR and dPCR. Subsequently, we developed a model, based on the Poisson and binomial distributions, to determine the variance inherent in dPCR.
News

National Cancer Institute Awards Two Lung Cancer CTC Development Contracts to Cynvenio Biosystems, Inc.

Company also announces additional equity investment of $2.0 million.
News

Aria Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Aria's Technology

Study, which exclusively examines women in their first trimester of pregnancy, provides largest data set to date for trisomy 18 pregnancies.
News

RPS Appoints Mark D. Myslinski Chief Executive Officer

Myslinski brings nearly 30 years of successful leadership experience in life sciences and diagnostic companies ranging from Fortune 100 companies to small, venture-backed start up organizations.
News

Aria Diagnostics Announces Launch of U.S. Clinical Study Comparing New Non-Invasive Prenatal Test to Current Standard

Additional information on company plans and activities to be shared with investors at the 30th Annual JP Morgan Healthcare Conference.
News

Aria Diagnostics Secures $52.7 Million in Oversubscribed Series C Financing

Financing will support development and commercialization of new non-invasive prenatal test.
News

Risk-Free Non-Invasive Prenatal Paternity Test Announced

International DNA testing company easyDNA Limited launched the new, 100% risk-free prenatal paternity test to supercede current invasive methodologies.
Advertisement